ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.
ZipBio has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
ZipBio's investors include NFX, MoreVC.
ZipBio is headquartered in Seattle, United States.
ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.
ZipBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ZipBio — Funding & Investors." VCBacked, September 5, 2024, https://www.vcbacked.co/company/zipbio. Accessed August 1, 2026.
VCBacked. (2024). ZipBio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/zipbio
{{cite web |title=ZipBio — Funding & Investors |url=https://www.vcbacked.co/company/zipbio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated